The central theme of this interdisciplinary translational research program revolves around the molecular toxicology of a nephrotoxic human carcinogen, aristolochic acid (AA). We will bring an interdisciplinary approach (chemistry, cell physiology and genetics) to bear on the pathogenesis of aristolochic acid? nephropathy, combining molecular epidemiology and toxicogenomics to provide insights into genetic factors? that contribute to susceptibility or resistance to this widespread disease,. Additionally, AAN serves as a? model for currently idiopathic kidney diseases and disorders characterized by fibrogenesis, and this research? provides a mechanistic strategic approach to environmental diseases in general.? ? Our long-term goals are to: (a) establish the molecular mechanisms by which aristolochic acids exert their? profound nephrotoxic and genotoxic effects in humans and animals; (b) relate the 3-D structures of AA-DNA? adducts to the mutagenic potential of these lesions and to establish structure-function relationships involved? in their removal by nucleotide excision repair; (c) utilize a mouse model of AAN to study biotransformation of? AA and to validate AA-DNA adducts as potential biomarkers of exposure and risk of disease; (d) identify? mouse and human genes involved in the cytotoxic response of renal proximal tubules to AA, differentiating? this singular effect from the genotoxic effects of AA on urothelial cells; (e) dissect the genetic and cellular? events involved in AA-induced renal interstitial fibrosis; (f) use molecular epidemiologic and toxicogenomic? approaches to explore the pathogenesis of a similar disease, endemic nephropathy, and its associated? urothelial cancer, and to identify genes that control development of this devastating disease.? ? Findings emanating from this research are expected to impact directly on public health. Most obviously,? establishing the relationship between dietary exposure to aristolochic acid and an increased risk of? nephropathy and urothelial cancer suggests preventive strategies that will mitigate and potentially eliminate? this nephropathy from the endemic region. In addition, as fibrogenesis is an irreversible process associated? with end-stage renal disease, interstitial lung diseases, hepatic cirrhosis and heart disease, our research has? the potential to impact disorders responsible for morbidity and mortality in the US and throughout the world.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
2P01ES004068-19A1
Application #
7303159
Study Section
Special Emphasis Panel (ZES1-TN-E (AG))
Program Officer
Reinlib, Leslie J
Project Start
1997-03-01
Project End
2012-05-31
Budget Start
2007-08-01
Budget End
2008-05-31
Support Year
19
Fiscal Year
2007
Total Cost
$1,507,845
Indirect Cost
Name
State University New York Stony Brook
Department
Pharmacology
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Yun, Byeong Hwa; Guo, Jingshu; Turesky, Robert J (2018) Formalin-Fixed Paraffin-Embedded Tissues-An Untapped Biospecimen for Biomonitoring DNA Adducts by Mass Spectrometry. Toxics 6:
Jelakovi?, Bojan; Vukovi? Lela, Ivana; Karanovi?, Sandra et al. (2015) Chronic dietary exposure to aristolochic acid and kidney function in native farmers from a Croatian endemic area and Bosnian immigrants. Clin J Am Soc Nephrol 10:215-23
Romanov, Victor; Whyard, Terry C; Waltzer, Wayne C et al. (2015) Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation. Arch Toxicol 89:47-56
Yun, Byeong Hwa; Sidorenko, Viktoriya S; Rosenquist, Thomas A et al. (2015) New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid. Toxicol Res (Camb) 4:763-776
Castells, Xavier; Karanovi?, Sandra; Ardin, Maude et al. (2015) Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid. Cancer Epidemiol Biomarkers Prev 24:1873-81
Jelakovi?, Bojan; Nikoli?, Jovan; Radovanovi?, Zoran et al. (2014) Consensus statement on screening, diagnosis, classification and treatment of endemic (Balkan) nephropathy. Nephrol Dial Transplant 29:2020-7
Ivkovi?, Vanja; Karanovi?, Sandra; Fištrek Prli?, Margareta et al. (2014) Is herbal tea consumption a factor in endemic nephropathy? Eur J Epidemiol 29:221-4
Yun, Byeong Hwa; Yao, Lihua; Jelakovi?, Bojan et al. (2014) Formalin-fixed paraffin-embedded tissue as a source for quantitation of carcinogen DNA adducts: aristolochic acid as a prototype carcinogen. Carcinogenesis 35:2055-61
Attaluri, Sivaprasad; Iden, Charles R; Bonala, Radha R et al. (2014) Total synthesis of the aristolochic acids, their major metabolites, and related compounds. Chem Res Toxicol 27:1236-42
Sidorenko, Viktoriya S; Attaluri, Sivaprasad; Zaitseva, Irina et al. (2014) Bioactivation of the human carcinogen aristolochic acid. Carcinogenesis 35:1814-22

Showing the most recent 10 out of 136 publications